We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-3.84%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$6.16B
AUM Growth
+$1.7B
Cap. Flow
+$2.17B
Cap. Flow %
35.15%
Top 10 Hldgs %
26.62%
Holding
7,028
New
630
Increased
3,221
Reduced
2,151
Closed
574

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$204M
2
MSFT icon
Microsoft
MSFT
+$195M
3
AMZN icon
Amazon
AMZN
+$97.4M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$95M
5
TSM icon
TSMC
TSM
+$69.5M

Sector Composition

Rank Sector Weight
1 Technology 26.99%
2 Healthcare 10.86%
3 Consumer Discretionary 10.71%
4 Financials 8.62%
5 Communication Services 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HGEN
5326
DELISTED
HUMANIGEN, INC.
HGEN
$4K ﹤0.01%
21,736
+12,368
+132% +$6.66K
BSFC
5327
DELISTED
Blue Star Foods Corp. Common Stock
BSFC
$4K ﹤0.01%
6
+4
+200% +$4.69K
TOAC
5328
DELISTED
Talon 1 Acquisition Corp. Class A Ordinary Shares
TOAC
$4K ﹤0.01%
416
-596
-59% -$6.04K
QTEK
5329
DELISTED
QualTek Services Inc. Class A Common Stock
QTEK
$4K ﹤0.01%
2,141
+569
+36% +$891
TRAQ.U
5330
DELISTED
Trine II Acquisition Corp. Units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant
TRAQ.U
$4K ﹤0.01%
424
BMAQ
5331
DELISTED
Blockchain Moon Acquisition Corp. Common Stock
BMAQ
$4K ﹤0.01%
423
+94
+29% +$935
ARVL
5332
DELISTED
Arrival Ordinary Shares
ARVL
$4K ﹤0.01%
100
-144
-59% -$9.48K
RAM
5333
DELISTED
Aries I Acquisition Corporation Class A Ordinary Share
RAM
$4K ﹤0.01%
394
+242
+159% +$2.5K
LHDX
5334
DELISTED
Lucira Health, Inc. Common Stock
LHDX
$4K ﹤0.01%
+3,550
New +$8.09K
OPNT
5335
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
$4K ﹤0.01%
434
-935
-68% -$10.6K
FTAAU
5336
DELISTED
FTAC Athena Acquisition Corp. Unit
FTAAU
$4K ﹤0.01%
393
LGACU
5337
DELISTED
Lazard Growth Acquisition Corp. I Units
LGACU
$4K ﹤0.01%
380
-3
-0.8% -$30
HZN
5338
DELISTED
Horizon Global Corporation
HZN
$4K ﹤0.01%
3,015
+1,418
+89% +$2.21K
LCI
5339
DELISTED
Lannett Company, Inc.
LCI
$4K ﹤0.01%
2,190
-1,797
-45% -$3.94K
PRBM.U
5340
DELISTED
Parabellum Acquisition Corp. Units, each consisting of one share of Class A common stock and three-quarters of one redeemable warrant
PRBM.U
$4K ﹤0.01%
+448
New +$4.44K
DNZ
5341
DELISTED
D and Z Media Acquisition Corp.
DNZ
$4K ﹤0.01%
404
-1
-0.2% -$10
NAAC
5342
DELISTED
North Atlantic Acquisition Corporation Class A Ordinary Share
NAAC
$4K ﹤0.01%
415
-750
-64% -$7.42K
FCAX
5343
DELISTED
Fortress Capital Acquisition Corp.
FCAX
$4K ﹤0.01%
452
-19
-4% -$188
STAB
5344
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$4K ﹤0.01%
30,946
+7,125
+30% +$1.5K
HCICU
5345
DELISTED
Hennessy Capital Investment Corp. V Units
HCICU
$4K ﹤0.01%
451
-1
-0.2% -$10
LHAA
5346
DELISTED
Lerer Hippeau Acquisition Corp. Class A Common Stock
LHAA
$4K ﹤0.01%
352
-21
-6% -$206
ZWRKU
5347
DELISTED
Z-Work Acquisition Corp. Units
ZWRKU
$4K ﹤0.01%
419
+10
+2% +$99
CRU
5348
DELISTED
Crucible Acquisition Corporation
CRU
$4K ﹤0.01%
447
-41
-8% -$405
AUS.U
5349
DELISTED
Austerlitz Acquisition Corporation I Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
AUS.U
$4K ﹤0.01%
396
RMO
5350
DELISTED
Romeo Power, Inc.
RMO
$4K ﹤0.01%
+11,246
New +$6.77K

Similar funds

Tower Research Capital (TRC)'s Q3 2022 Portfolio in Review

As of Q3 2022, Tower Research Capital (TRC) held 7,028 positions worth $6.16B, up 38% from $4.46B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $2.17B of net new capital in Q3 2022, opening 630 new positions and adding to 3,221 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $53M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2022 buy was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.
  • Tower Research Capital (TRC) added most to Apple in Q3 2022, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $53M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Portfolio S&P 500 ETF in Q3 2022, selling an estimated $6.39M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $6.16B portfolio in Q3 2022.
  • Tower Research Capital (TRC) opened 630 new positions and closed 574 in Q3 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 38% quarter-over-quarter to $6.16B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.